NEW YORK (GenomeWeb News) - Caliper Life Sciences today said second-quarter revenues increased 45 percent as R&D spending grew 35 percent and net loss more than tripled.
 
Total receipts for the three months ended June 30 increased to $35.3 million from $24.3 million year over year.
 
Product sales contributed $21 million, a 71 percent increase year over year; services brought in $8.9 million, a 66 percent increase; and licensing and contracts fell 20 percent to $5.3 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.